Invo Fertility Inc. has expanded services at its Wisconsin clinic by adopting time-lapse incubation technology for embryo development monitoring. The company said the FDA-cleared system enables continuous imaging without removing embryos from a stable environment, supporting embryo assessment and selection and allowing patients to receive a video record of development. INVO described the move as part of its broader investment in laboratory excellence and clinical quality across its clinic network.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603050900PRIMZONEFULLFEED9666323) on March 05, 2026, and is solely responsible for the information contained therein.
Comments